|
|
|
Corporate Profile: Calypte Biomedical Corporation
| Summary: |
Calypte Biomedical Corporation is focused on the development and commercialization of in vitro tests to diagnose Human Immunodeficiency Virus (HIV) infection, sexually transmitted disease infections and other chronic diseases.
|
| Address (HQ): |
15875 SW 72nd Avenue
Portland, OR 97224 |
| Phone #'s (HQ): |
| Main |
(503) 726-2227 |
| Human
Resources |
not known |
| Investor
Relations |
not known |
| Fax #'s (HQ): |
| Main |
(503) 601-6299 |
| Human
Resources |
not known |
| Investor
Relations |
not known |
| Financial
information: |
| CBMC |
| Issued United States patents: |
| Issued U.S. patents: 1976-present: patent
link. |
| Filed United States patent applications: |
| Filed U.S. patent applications: 2001-present: patent
link. |
| Publications on PubMed: |
| Scientific publications on PubMed with an author from the company: publications
link. |
|
|
|
